PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ)
$1.05 -0.07 (-6.25%)
Analysed PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) News Sources
PDS Biotechnology Corp (PDSB) Q4 2025 Earnings Call Highlights: Financial Discipline Amid ...
31-03-2026
yahoo.com
PDS Biotechnology Corporation Q4 2025 Earnings Call Summary
31-03-2026
moby.co
PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial
15-04-2026
yahoo.com
PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
06-05-2026
yahoo.com
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
13-05-2026
yahoo.com
PDS Biotechnology Q1 2026 Earnings Call: Complete Transcript
13-05-2026
yahoo.com
PDS Biotechnology Corporation Q1 2026 Earnings Call Summary
13-05-2026
moby.co
PDS Biotechnology Q1 Earnings Call Highlights
13-05-2026
marketbeat.com
PDS Biotechnology Corp (PDSB) Q1 2026 Earnings Call Highlights: Strategic Advancements and ...
13-05-2026
yahoo.com
Here's Why PDS Biotechnology (PDSB) Could be Great Choice for a Bottom Fisher
10-06-2026
yahoo.com
What is the current price of PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ)?
The current price of PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) is $1.05.
PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) absolute price change since previous trading day?
The absolute price change of PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) since the previous trading day is $-0.07.
PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) percentage price change since previous trading day?
The percentage price change of PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) since the previous trading day is -6.25%.
What is the most recent average sentiment score for PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ)?
The most recent average sentiment score for PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ)?
The most recent sentiment for PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ) is .
SEC-8K** Filing Available For PDS BIOTECHNOLOGY CORP (PDSB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.